Article ; Online: Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?
Clinical & experimental metastasis
2021 Volume 38, Issue 3, Page(s) 257–261
Abstract: Cancer patients represent a vulnerable cohort during the Sars-CoV-2 pandemic. Oncological societies ... nosocomial infections were registered. However, Validation of our measures is outstanding and regional SARS-CoV-2 ... results, especially for advanced cancer stages during this and future pandemia. In the future ...
| Abstract | Cancer patients represent a vulnerable cohort during the Sars-CoV-2 pandemic. Oncological societies have generated a plethora of recommendations, but precise instructions about routine oncological procedures remain scarce. Here, we report on local COVID-19 protection measures established in an interdisciplinary approach at a tertiary care center during the first wave of the pandemia in Germany. Following these measures, no additional morbidity or mortality during oncological procedures was observed, and no nosocomial infections were registered. However, Validation of our measures is outstanding and regional SARS-CoV-2 prevalence was low. However, specific oncological measures might be important to ensure optimal oncological results, especially for advanced cancer stages during this and future pandemia. In the future, communication about these measures might be crucial to a cancer patient´s assigned network to reduce the danger of excess mortality within the second wave of the COVID-19 pandemic. |
|---|---|
| MeSH term(s) | COVID-19/epidemiology ; COVID-19/prevention & control ; COVID-19/transmission ; COVID-19/virology ; Germany/epidemiology ; Humans ; Infection Control/methods ; Infection Control/organization & administration ; Infection Control/standards ; Medical Oncology/methods ; Medical Oncology/organization & administration ; Medical Oncology/standards ; Neoplasms/complications ; Neoplasms/immunology ; Pandemics/prevention & control ; Pandemics/statistics & numerical data ; Prevalence ; SARS-CoV-2/immunology ; SARS-CoV-2/pathogenicity ; Tertiary Care Centers/organization & administration |
| Language | English |
| Publishing date | 2021-03-23 |
| Publishing country | Netherlands |
| Document type | Journal Article ; Research Support, Non-U.S. Gov't |
| ZDB-ID | 604952-7 |
| ISSN | 1573-7276 ; 0262-0898 |
| ISSN (online) | 1573-7276 |
| ISSN | 0262-0898 |
| DOI | 10.1007/s10585-021-10083-1 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1855: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.